User profiles for Konstantinos Tsiakos
 | Konstantinos Tsiakos, MD, Phd(c)National and Kapodistrian University of Athens, Medical School Verified email at med.uoa.gr Cited by 970 |
[HTML][HTML] Early treatment of COVID-19 with anakinra guided by soluble urokinase plasminogen receptor plasma levels: a double-blind, randomized controlled phase 3 …
…, H Milionis, S Metallidis, G Adamis, K Tsiakos… - Nature medicine, 2021 - nature.com
Early increase of soluble urokinase plasminogen activator receptor (suPAR) serum levels is
indicative of increased risk of progression of coronavirus disease 2019 (COVID-19) to …
indicative of increased risk of progression of coronavirus disease 2019 (COVID-19) to …
[HTML][HTML] Effect of anakinra on mortality in patients with COVID-19: a systematic review and patient-level meta-analysis
…, A Koliakou, G Poulakou, K Tsiakos… - The Lancet …, 2021 - thelancet.com
Background Anakinra might improve the prognosis of patients with moderate to severe
COVID-19 (ie, patients requiring oxygen supplementation but not yet receiving organ support). …
COVID-19 (ie, patients requiring oxygen supplementation but not yet receiving organ support). …
An open label trial of anakinra to prevent respiratory failure in COVID-19
…, S Georgiadou, O Tsachouridou, V Petrakis, K Tsiakos… - Elife, 2021 - elifesciences.org
Background: It was studied if early suPAR-guided anakinra treatment can prevent severe
respiratory failure (SRF) of COVID-19. Methods: A total of 130 patients with suPAR ≥6 ng/ml …
respiratory failure (SRF) of COVID-19. Methods: A total of 130 patients with suPAR ≥6 ng/ml …
[HTML][HTML] ACTIVATE-2: a double-blind randomized trial of BCG vaccination against COVID-19 in individuals at risk
…, C Delavinia, I Perdios, A Pandi, K Tsiakos… - Frontiers in …, 2022 - frontiersin.org
In a recent study of our group with the acronym ACTIVATE, Bacillus Calmete-Guérin (BCG)
vaccination reduced the occurrence of new infections compared to placebo vaccination in the …
vaccination reduced the occurrence of new infections compared to placebo vaccination in the …
Influenza vaccination in cancer patients treated with immune checkpoint inhibitors: a systematic review and Meta-analysis
The safety and efficacy of influenza vaccination is not well-studied in cancer patients
receiving immune checkpoint inhibitors (ICIs). A systematic review and meta-analysis was …
receiving immune checkpoint inhibitors (ICIs). A systematic review and meta-analysis was …
Clarithromycin for early anti-inflammatory responses in community-acquired pneumonia in Greece (ACCESS): a randomised, double-blind, placebo-controlled trial
…, S Doulou, N Kakavoulis, K Tsiakos… - The Lancet …, 2024 - thelancet.com
Background Addition of macrolide antibiotics to β-lactam antibiotics for the treatment of patients
in hospital with community-acquired pneumonia is based on results from observational …
in hospital with community-acquired pneumonia is based on results from observational …
[HTML][HTML] Early start of oral clarithromycin is associated with better outcome in COVID-19 of moderate severity: the ACHIEVE open-label single-arm trial
K Tsiakos, A Tsakiris, G Tsibris, PM Voutsinas… - Infectious Diseases and …, 2021 - Springer
… Konstantinos Tsiakos participated in data analysis, drafted the manuscript, had full access
to all of the study data and takes responsibility for their integrity and the accuracy of the …
to all of the study data and takes responsibility for their integrity and the accuracy of the …
Current perspectives on the diagnosis and management of healthcare-associated ventriculitis and meningitis
Ventriculitis or post-neurosurgical meningitis or healthcare-associated ventriculitis and
meningitis (VM) is a severe infection that complicates central nervous system operations or is …
meningitis (VM) is a severe infection that complicates central nervous system operations or is …
[HTML][HTML] Programmed Cell Death Protein 1 Axis Inhibition in Viral Infections: Clinical Data and Therapeutic Opportunities
A vital function of the immune system is the modulation of an evolving immune response. It
is responsible for guarding against a wide variety of pathogens as well as the establishment …
is responsible for guarding against a wide variety of pathogens as well as the establishment …
[HTML][HTML] ICU-associated gram-negative bloodstream infection: risk factors affecting the outcome following the emergence of colistin-resistant isolates in a regional …
M Karvouniaris, G Poulakou, K Tsiakos… - Antibiotics, 2022 - mdpi.com
Intensive care unit patients may present infections by difficult-to-treat-resistant Gram-negative
microorganisms. Colistin resurfaced as a last resort antibiotic for the treatment of multi-drug…
microorganisms. Colistin resurfaced as a last resort antibiotic for the treatment of multi-drug…
